Possible impact of factor V Leiden genotype on warfarin induced bleeding
Sir,
We read with interest the report, recently published by Nahar et al. [1] on the prevalence of warfarin sensitive alleles in factor V Leiden (FVL) mutation carriers.
The study provides preliminary evidence for the need of pre-prescription genotyping of warfarin sensitive beneficial in all the patients prior to the initiation of anticoagulation therapy. [3] Another important aspect of coinheritance of thrombophilia is its impact on the bleeding phenotype.
Several studies, both in vitro and case series have shown that FVL mutation modulates the clinical severity in hemophilia and other rare bleeding disorders. [4, 5] We therefore premise that FVL carrier patients should be at 
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Letter to the Editor Table 1 : Genotype and allele frequencies of CYP2C9 and VKORC1 in few studies from India Genotypes/Alleles Nahar et al. [1] (FVL carrier patients) N=61
Shalia et al. [2] (normal and patients operated for aortic or mitral valve replacement) N=183
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